CuraSen Therapeutics
San Carlos, CA
Curasen Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. Curasen Therapeutics serves customers in the State of California.
curasen.comCompany Details
Founded
- 2016
Employees
- Between 20 - 50 employees
Raised
- $101,685,016
Headquarters Location
- San Carlos, CA
Public
- No
Acquired
- No
CEO
Kathleen Sereda Glaub
Founders
- Mehrdad ShamlooKathleen Sereda GlaubRobert BoothAnthony Ford
Company Collections
These are collections CuraSen Therapeutics is a part of. Click on the collection name to view similar companies.
CuraSen Therapeutics' Industries
CuraSen Therapeutics Headquarters Location
930 Brittan Ave #306, San Carlos, CA 94070
Total Amount Raised: $101,685,016
CuraSen Therapeutics Funding Rounds
Series Unknown
$5,785,019
Grant
$5,800,000
Grant Investors
Alzheimer's Drug Discovery FoundationSeries Unknown
$17,599,997
Series Unknown
$18,000,000
Series A
$54,500,000
Series A Investors
New Leaf Venture PartnersAlta PartnersLongitude CapitalTekla Capital ManagementJohnson & Johnson InnovationPappas CapitalChiesi Ventures
Funding info provided by Diffbot.
CuraSen Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on CuraSen Therapeutics.